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Abstract
Over the last five decades, healthcare advances have yielded quantum improvements in life 
expectancy for individuals with congenital genitourinary conditions (CGCs), leading to a crisis of 
care. Many individuals with CGC enter adulthood unprepared to manage their condition. Pediatric 
CGC specialists lack training to manage adulthood-related healthcare issues, while adult 
genitourinary specialists lack training within the context of CGCs. To address these challenges, the 
National Institutes of Diabetes and Digestive and Kidney Diseases convened individuals with 
CGCs and experts from a variety of fields to identify research needs to improve transitional 
urology care. This manuscript outlines identified research needs.
Keywords
congenital genitourinary conditions; care transitions; spina bifida; neurogenic bladder; bladder 
exstrohpy; disorders of sex development
INTRODUCTION
Over the last five decades, advances in pediatric urology and overall healthcare have resulted 
in quantum improvements in life expectancy and quality of life (QoL) for individuals with 
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congenital genitourinary conditions (CGCs). Specifically, the improved survival of people 
with spina bifida, bladder/cloacal exstrophy, disorders of sex development, and obstructive 
uropathy (i.e., posterior urethral valves) has led to a veritable "tidal wave" of individuals 
with CGCs reaching young adulthood.1–3 Many enter adulthood ill-prepared to manage their 
condition or handle issues such as sexuality and fertility.4, 5 Pediatric genitourinary 
specialists with expertise in complex CGCs often view sexuality and fertility as outside the 
scope of their practice, while adult genitourinary specialists lack specific training on these 
topics within the context of CGCs. This has resulted in a crisis of care in the field: 
individuals with CGCs who were provided excellent, often multidisciplinary care in 
childhood but are at risk of receiving suboptimal urologic care in adulthood.6–9
The traditional clinical approach that divides the lifespan into “pediatric,” “adult,” and 
“geriatric” phases has proven disadvantageous for our understanding of patients with CGCs. 
An increasing awareness that healthcare decisions made in childhood influence health 
behaviors in adulthood has pushed providers to examine how children, families and young 
adults are prepared for transition to an adult-care model. Broadly defined as “transitional 
care,” this practice has been endorsed by organizations including the American Academy of 
Pediatrics (AAP), American College of Physicians (ACP) and American College of Family 
Physicians (ACFP).5 Transition is a complex process that takes place in multiple inter-
related domains: school-to-work, home-to-community, and pediatric-to-adult healthcare. 
One framework for transition quality improvement is composed of six elements: establishing 
a policy, tracking progress, administering transition readiness assessments, planning for 
adult care, transferring, and integrating into an adult practice (Got Transition [http://
www.gottransition.org]).5
According to the World Health Organization’s (WHO) International Classification of 
Function, Disability and Health (ICF) model, high-quality care encompasses not only health-
related outcomes, but also activities, social participation, and environmental factors to 
address an individual’s ability to fully function in society.10 This approach requires 
interdisciplinary collaboration among healthcare providers, patients, family caregivers, 
educators and community-based rehabilitation service providers, including occupational 
therapists, behavioral specialists, social workers and personal care attendants.
Interdisciplinary care is imperative for individuals with CGCs, who have disproportionate 
rates of infectious, renal, reproductive, and neurocognitive complications, many evolving 
across the lifespan and emerging or changing during adolescence and young adulthood 
(Figure 1), when individuals are transitioning from pediatric to adult care. During this 
transition, individuals may encounter issues regarding their reproductive health. A 
substantial number of urogenital disorders occur in the context of intellectual disability 
and/or developmental disability (e.g. Prader-Wili Syndrome, spina bifida). Collaboration 
with family caregivers, educators, and community-based habilitation service providers is 
particularly important for these patients.
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METHODS
In response to the challenges to delivery of transitional urologic care, the National Institutes 
of Health’s National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) 
convened individuals with CGCs and experts from a variety of health fields, including 
urology, adolescent and developmental pediatrics, nephrology, gynecology, epidemiology, 
nursing, and public health, to identify research needs to improve transitional care. 
Individuals with CGCs presented their experiences and lessons learned during their own 
transitions. Experts presented clinical challenges pertaining to adolescents with CGCs. The 
remainder of the meeting consisted of two sets of breakout sessions (Figure 2). First, six 
multidisciplinary groups of participants identified research areas of highest and intermediate 
need across six condition-based areas. Then, participants reassembled into six groups to 
discuss the identified condition-based needs across scientific disciplines. Afterwards, all 
participants reconvened for a facilitated discussion to summarize major research needs. A 
meeting summary is available.11
FINDINGS AND RECOMMENDATIONS
Priority research needs identified during the meeting are presented below, organized by the 
elements of WHO’s ICF model (i.e., environmental factors, body structures and function, 
activities and participation) and the two primary domains of urologic care: the urinary tract 
and reproductive system.
Environmental Factors
Healthcare delivery systems to improve continuity of care—As with many 
populations with chronic health conditions, continuity of care is highly relevant to 
individuals with CGCs. Young adulthood is a critical and high-risk period, as responsibilities 
for self-management and health maintenance transition from the parent/caregiver to the 
adolescent who may be ill prepared for this role. Unhealthy behaviors are often initiated 
during this period, when many young adults experience a lapse in routine health 
maintenance previously facilitated by their parents.12 This can be exacerbated by insurance 
challenges as young adults transition from family to individual insurance coverage. Before 
the Affordable Care Act, many young adults with congenital conditions were uninsurable 
and failed to maintain recommended healthcare in adulthood. Access challenges may be 
heightened for young adults with CGCs and intellectual disability or developmental 
disability (ID/DD). The complexity of healthcare financing for patients with ID/DD—which 
requires navigation of publicly funded insurance programs—may limit access to care. 
Physical access to healthcare facilities also is a concern in some practice environments. 
Testing, validation, and comparative analyses of transitional care models and alternative 
payment models are needed to determine how to best organize and deliver urologic care to 
individuals with CGCs transitioning to adulthood.
Barriers and facilitators to successful transition—Even among established spina 
bifida clinics, only 68% have a written transition policy, and only half of those routinely 
evaluate their transition process.13 Within organizations with established transition clinics in 
the same location and with overlapping providers, low rates of successful transition have 
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been reported (R. Misseri, personal communication). Barriers to successful transition have 
not been well-defined, but may include: (1) systemic (i.e., incompatibility in insurance 
coverage between providers, electronic medical records, or hospitals); (2) physical (i.e., lack 
of transportation or facilities ill-equipped for examination and treatment of patients with 
disabilities); (3) psychoemotional (i.e., resistance of the patient or pediatric provider to “let 
go” of the relationship); and (4) educational/training (i.e., lack of expertise in the available 
adult-care pool, limited opportunities for training across systems of care such as habilitation 
services).
Standardized healthcare pathways—Developing clinical pathways (e.g., 
pharmacologic treatment, behavioral treatments, diagnostic guidelines, patient education 
recommendations) and procedural interventions (e.g., self-intermittent catheterization, 
bladder irrigation, surgical treatments) to establish healthcare pathways with less variability 
than currently exist for management of individuals with CGCs could potentially facilitate 
wider and more consistent access to care and follow-up/surveillance protocols.
Specialist training—Intrinsic differences in training of pediatric versus "general" 
gynecologists and urologists contribute to suboptimal care of adolescents and young adults 
with urologic conditions requiring lifelong follow-up.14 The adult-onset health issues 
experienced by people with CGCs require expertise that is not yet widely available. 
Assessments are needed to determine the education and training needed to prepare urologic 
specialists to effectively manage adult-onset health issues in individuals with CGCs. 
Additionally, training interventions must be developed and implemented.
Individuals with ID/DD may face additional barriers, as adult urologists often lack specific 
information about the functional goals, habilitation needs, communication style, and 
decision-making abilities of patients with ID/DD. Understanding neuronal plasticity and 
“critical windows” or sensitivities for development of executive functioning may help 
clinicians better time self-management interventions as individuals with CGCs and ID/DD 
transition to adulthood.
Interventions to improve urology referrals—Access to healthcare and the quality of 
healthcare can be problematic for individuals with CGCs, especially among those who also 
have ID/DD. Diagnostic overshadowing (e.g., the tendency for clinicians to attribute 
incontinence to the disability) can result in delayed referrals to urologists and incomplete 
diagnostic evaluations. This limits timely access to appropriate therapeutic care. Research 
must be conducted to understand how best to encourage appropriate referral to urologic 
specialists for individuals with CGCs and ID/DD.
Urinary Tract
Body Structure and Function
Epidemiology and natural history of congenital neuropathic bladder: The rarity and 
heterogeneity of CGCs and the temporal limit of pediatric care, inhibit understanding of the 
epidemiology and natural history of CGCs. While the underlying pathologic process may be 
divergent for many individuals with congenital neurogenic bladder (NGB), most can be 
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broadly characterized by a combination of storage and voiding mechanisms (Table 1). 
Classifying patients into these groups often permits characterization of patients for 
surveillance and management. However, we lack a phenotypic classification scheme for 
congenital NGB in adulthood with specific considerations for special populations. For 
example, a patient with spina bifida managed during childhood with augmentation 
cystoplasty may have more in common with a similarly managed patient with exstrophy 
compared to another patient with spina bifida who voids by Valsalva maneuvers. 
Epidemiological characterization of individuals with CGCs, including rates of supravesical 
diversion, acute kidney injury (AKI), end-stage renal disease (ESRD), bladder cancer, 
urolithiasis, and urinary tract infection (UTI), must be defined so that surveillance protocols 
and best practices can be developed. Because existing registries and databases are 
insufficient for understanding CGCs and their complications across the lifespan, developing 
new and enhancing existing registries may facilitate an increased understanding of the 
epidemiology of CGCs and related complications.
Relationship between congenital NGB and bladder cancer: While many studies have 
reported an elevated risk of bladder cancer in congenital bladder diseases (i.e., bladder 
exstrophy and adenocarcinoma),15, 16 the absolute risk remains poorly defined.17, 18 While 
still rare, these cancers often impart significant morbidity and are almost universally fatal. 
Prevention and surveillance strategies for urinary reservoirs that contain bowel and are 
chronically bacteriuric have not been defined. Moreover, recurrent UTI as a potential 
mechanism of increased bladder cancer risk remains poorly understood. Little is known 
about the role chronic inflammation and/or underlying congenital bladder disease may play 
in bladder oncogenesis. Hypotheses that have been posed but remain unproven include 
concepts that UTI-induced inflammation may promote a microenvironment conducive to 
malignant transformation of the bladder urothelium.19 Another theory is that uropathogenic 
bacteria produce metabolic products, such as nitrosamines, which may facilitate urothelial 
carcinogenesis.20
Bladder microbiome: Molecular-based, non-culture-dependent methods of characterizing 
microbes in the human body have revealed a previously unappreciated microverse.21 
Conventional urine cultures may only represent the "tip of the iceberg," and defining how 
the multitudes of bacteria may interact to prevent or cause UTI will be critical to the care of 
transitional patients with NGB.22 The urine microbiome, and associated UTI risk factors, 
may change as a function of patient age. For instance, puberty results in estrogenization of 
the vagina, fostering the growth of lactic acid-producing bacteria, which in turn provide a 
microbiological barrier to uropathogenic bacteria.23 Conversely, menopause is linked to loss 
of estrogenization of the vagina, and the resulting vaginal atrophy has been associated with 
increased UTI risk.24 Pregnant women with a history of vesicoureteral reflux during 
childhood appear to be at increased risk of UTI.25, 26 Interestingly, these small retrospective 
series also suggest that pregnant women who underwent childhood surgical repair of reflux 
(a set of procedures with >90% success rates) also seem to be susceptible to UTI. These 
initial observations need to be confirmed using prospective cohorts.
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Recently described processes such as the development of intracellular bacterial communities 
within urothelial cells, where bacteria can "hide" from the immune system and antibiotics, 
may contribute to recurrent UTI in patients with NGB.27 A more comprehensive 
understanding of these processes may help identify new therapeutic targets for UTI in this 
patient population, which is particularly relevant given the high rates of antibiotic resistance 
among bacterial isolates derived from these patients.
Asymptomatic bacteruria versus UTI: Many patients requiring lifelong urologic care have 
abnormal bladders and are chronically bacteriuric due to bladder colonization.28 The 
distinction between asymptomatic bacteriuria and UTI, particularly in patients with sensory 
and/or intellectual disability that alter symptoms, is not established. Guidelines defining best 
practices for diagnosis and treatment of UTI in patients with congenital NGB are critically 
needed.
Assessing kidney function: Monitoring renal function and appropriate medical 
interventions are important to prevent progressive chronic kidney disease (CKD) and ESRD. 
In clinical practice, estimated glomerular filtration rate (eGFR), which is calculated from 
serum creatinine level using estimating equations, is commonly used to define kidney 
function.29, 30 However, creatinine-based estimates of GFR have many limitations that may 
be relevant for populations with CGCs, particularly spina bifida.31 These include: (1) 
reduced muscle mass on serum creatinine levels, which reduces accuracy of creatinine-based 
equations in individuals with low lean body mass, and (2) change in serum creatinine 
because of common CGC medications (e.g., artificial elevation of serum creatinine with 
antibiotics like trimethoprim-sulfamethoxazole and cefoxitin). Cystatin C-based equations 
for assessing eGFR may be a promising alternative in populations with CGCs.32 For renal 
scarring, dimercapto-succinic acid scan is the imaging method of choice.33 However, wide 
access to the nuclear tracer needed for this study has been problematic, limiting clinical 
utilization. Thus, research is needed to clarify the best means by which to evaluate kidney 
function in transitional urologic patients.
Etiology, prevention and management of kidney diseases: Although kidney diseases are 
common in CGC, prevention methods and ideal management are not clear. Potential 
contributors to kidney disease in CGC are diverse and vary by condition. Among children 
with spinal dysraphism, high-grade reflux is associated with the highest risk for renal 
cortical loss.34 UTI, particularly in the presence of vesicoureteral reflux, increases the risk of 
renal scarring, which can cause hypertension, proteinuria, pregnancy-related problems and 
progressive CKD, including ESRD in some patients.33, 35 Urodynamic risk factors for the 
development of CKD include detrusor sphincter dyssynergia, detrusor overactivity, high 
detrusor leak point pressure and high intravesical pressure. UTIs in childhood are also linked 
to renal dysfunction later in life.36, 37 In patients with diminished renal function, serum 
creatinine levels are known to increase during late adolescence. This may be related to 
disease progression, poor adherence to catheterization schedules and medications, increased 
bladder outlet resistance due to prostatic growth, alterations in creatinine metabolism and 
estrogenization of the female urethra and/or tethering of the spinal cord.38
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Few studies have focused on renal outcomes in adolescents and adults with congenital NGB 
and vesicoureteral reflux. Recent studies suggest that death from renal failure in well-
managed patients is much lower than that reported for historical cohorts.39, 40 Changes in 
continence, recurrent UTI, weight gain, hypertension, proteinuria, and urolithiasis may 
independently affect renal function. In addition, some of these conditions may indicate a 
change in bladder dynamics. Each may ultimately contribute to upper tract changes and 
renal disease. With each episode of pyelonephritis, the risk of renal scarring increases, 
nephrons are lost and renal failure may ensue. Antibiotic prophylaxis may be helpful in 
carefully selected patients. Kidney stones are also a risk factor for CKD and progression to 
ESRD.41 Treatment with angiotensin-converting enzyme inhibitors may prevent CKD 
progression.42, 43 Progressive CKD may result in metabolic complications; however, 
evidence is limited regarding risk factors for these complications and effective interventions 
to prevent them.
Activities and Participation
Assessing treatment history, patient disease state knowledge, and patient self-care: As 
individuals with CGCs receive medical care and often undergo surgery in childhood, they 
frequently rely on parents and other surrogates to act as “historian,” understand their disease 
state (e.g., bladder or renal function), and help with self-care. As parents/caregivers begin to 
withdraw from care during patient transition to adulthood, the individual with CGC may be 
left with severe limitations in the extent and accuracy of self-knowledge about their disease 
state and medical history and in their self-care abilities. Such assessments should include 
knowledge of the rationale for care requirements (e.g., preservation of renal function, 
continence, reduction of infection and stone risk), dexterity, cognitive ability and 
responsibility for self-management, communication skills, and the patient’s capacity for 
troubleshooting bladder and urinary tract management relative to equipment and technique 
(e.g., stomal access, prolonged retention, appliance seal, catheter occlusion). If ability for 
self-care is limited, the need to engage family, aides and other assistants is essential, but the 
optimal approaches for such engagement remain poorly defined.
Strategies to improve healthcare engagement and self-management: During adolescence 
and young adulthood, physical development precedes emotional maturity, and as a result, 
organizational skills and logical reasoning may not be optimal.44 Despite these challenges, 
the ability to engage the healthcare system is a necessary skill for individuals with CGCs in 
transition. Young adults with CGCs often face significant self-management demands, many 
of which may have previously been facilitated by a parent or caregiver. Additionally, 
engagement with the healthcare system is central to identification and management of 
complications. Social Learning Theory,45 which posits that learning is a cognitive process 
that takes place in a social context, and its concept of reciprocal determinism may provide a 
lens for considering adolescent health behaviors. Reciprocal determinism suggests that, just 
as an individual’s behavior is influenced by the environment, the environment is also 
influenced by the individual’s behavior. That is, the expectation of competence is essential to 
the development of competence. Studies have shown that children who are given household 
chores at an early age (“required helpfulness”) have better social outcomes in adulthood.46 
Transposed to skills such as hygiene and catheterization, the expectation of competence 
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(wellness model) may be more effective than medicalization of self-care skills (deficit 
model). Similarly, expectations of patient participation in decision-making may support self-
determination, or the ability to make choices and decisions based on their own preferences, 
to monitor their own actions and to be goal-oriented and self-directing. Understanding how 
health care providers foster self-management is a research priority. Studies are needed to 
delineate how health care providers and processes for developing effective self-management 
behaviors during transition relate to overall health and QoL.47
For individuals with ID/DD, supported decision-making—a process in which people receive 
the help they need and want to understand the situations and choices they face, so they can 
make life decisions for themselves, without the need for undue guardianship—was 
introduced in 2007 at the United Nations Convention on the Rights of Persons with 
Disabilities.48 Self-determination and supported or shared decision-making are key concepts 
for promoting health literacy of patients with CGCs—especially those with ID/DD. The 
ability of patients to make informed decisions and participate in their own healthcare 
correlates with adherence, satisfaction with care, and health outcomes. Research is needed to 
examine the impact of hygiene and self-care skills on social participation, assess the 
effectiveness of wellness programs and healthcare delivery models (e.g., group visits) that 
encompass social learning, and evaluate self-determination and supported or shared 
decision-making programs adapted to the urologic care setting. Additional strategies to 
improve treatment adherence, self-management and engagement may include a combination 
of health education, parental involvement, and self-monitoring.49 Whether and how 
development and use of electronic communication, telephone access, and local care 
providers to facilitate engagement, thereby minimizing delays in treating complications, and 
improving the efficacy and safety of care, remains to be determined.
Screening tools to assess executive function: Adolescence is a period of rapid cognitive 
and executive function development. Executive function skill development may vary from 
person to person, affecting their ability to interact with the healthcare team and perform self-
management activities. Executive function may be further complicated in individuals with 
ID/DD. Understanding executive function in young adults with CGCs will be critical to 
ensuring appropriate engagement as their healthcare responsibility increases during 
transition. Because neuropsychological testing is not always covered by insurance, 
incorporation of school-based psycho-educational reports into the medical record may be a 
cost-effective method to improve the understanding of IQ and adaptive functioning skills. 
Several tools exist that may be adapted and validated in the adolescent CGC population.50–52
Impact of aging and condition-related disability on continence management and 
bladder care: While an incontinent diversion such as a urinary conduit may represent “end-
stage” management, patients with congenital NGB may migrate through several 
pathophysiologic mechanisms of emptying and storage (Table 1) throughout their lifetime as 
they experience age- or condition-related disability. Examples of age-related conditions that 
may alter bladder management are provided in Table 2. Condition-related disability that 
occurs with aging is particularly relevant for congenital conditions that are multi-system, 
like spina bifida and cerebral palsy (Table 3).
Hsieh et al. Page 9
Urology. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Effects of renal impairment on QoL: Many studies have been published on QoL 
consequences of progressive CKD and ESRD.53, 54 Multiple tools exist to evaluate QoL; 
however, further validation through appropriately designed prospective studies is necessary 
in adolescents with CGCs to better understand QoL outcomes in this population.
Relationships among urinary and fecal continence and self-esteem: Many patients with 
“continent” bladder management routines (like intermittent self-catheterization or 
Mitrofanoff channels) experience varying levels of urinary incontinence (UI). In a French 
multicenter study, urinary continence outcomes were evaluated in periadolescents and young 
adults with spina bifida undergoing surgical treatment for UI.55 While the results suggested 
higher urinary continence rates among those who underwent operations (compared with 
those managed medically), some level of UI remained the norm for most.55 Bowel disorders
—including fecal incontinence—also are common in adolescents with NGB and are 
associated with social stigma in children and adults.56 Thus, despite the fact that higher 
levels of urinary continence have been demonstrated to result in improved self-esteem,57 
relationships between self-esteem, and urinary and fecal incontinence are not well 
characterized in adolescents with CGCs.
Effects on social participation: Toileting issues and the need for ongoing healthcare at a 
greater frequency than that of their peers can uniquely influence employment and 
educational opportunities. Toileting issues may be particularly challenging in group housing 
scenarios, as commonly encountered in undergraduate and graduate education. There are 
likely significant knowledge deficits and misconceptions regarding the impact of clean 
intermittent catheterization, urostomy care and indwelling catheters among patients and 
society at large. In spite of broad provisions of the Americans with Disabilities Act (ADA) 
regarding accommodation and accessibility, concerns for bathroom access, social 
embarrassment, risks surrounding transmission or acquisition of infection, and physical 
limitations may hamper patient educational and employment opportunities. Particularly 
among patients who use catheterization to manage continence, these issues are exacerbated 
by any acute lower urinary tract symptoms associated with UTI. Coping with acute UTI 
symptoms may contribute to time away from school, work, family and friends. 
Consequently, further study and clarification of these issues is necessary to reduce obstacles 
to societal participation of young adults with CGCs as they transition to adulthood.
Reproductive System
Body Structures and Function
Epidemiology: Functional issues will be highly variable depending on whether the CGC is 
primarily genital (e.g., exstrophy-epispadias) or neurological (e.g., spina bifida) and on 
gender, experience and age of the individual. Knowledge of the rates of sexual dysfunction 
among men and women in these populations is limited at best.58 To develop reliable 
estimates of sexual dysfunction, validated measures of erectile, ejaculatory, sensory, 
orgasmic and pain symptoms associated with intercourse need to be developed. Similarly, 
patients with CGCs can demonstrate risk factors for hypofertility and infertility related to 
anatomical, physiological, functional, or endocrine-related comorbidities. For some 
conditions, fertility risks have been described;59 however, these include largely small, single-
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center studies. Among individuals with CGCs, changes in body structure and function, 
including gonadal failure or gonadectomy, fallopian tube damage after multiple operations, 
and anatomical anomalies of internal organs impact fertility. Men with CGCs also can be 
infertile due to a variety of issues resulting from their underlying condition. In men with 
Eagle Barrett syndrome, fertility is impaired because of ejaculatory dysfunction from 
bladder neck incompetence and megalo-urethra obstruction caused by an absent/atretic vas 
deferens and cryptorchidism. Men with exstrophy or spina bifida, however, often have a 
combination of erectile, ejaculatory, and spermatogenic defects that render them infertile. In 
many cases, infertility and heritability risks are either so complex or so poorly understood by 
the practicing urologist/gynecologist that adequate evaluation and counseling is not feasible.
Oncologic risks: Although there have been reports of increased risk for seminoma in testes 
of XY females, as well as development of cancers in bowel neovaginas, the exact risk is 
unclear. Certain disorders of sexual development are associated with increased risk of 
gonadal tumors, but the risk is based on case series and optimal treatment is poorly 
understood. Many undergo gonadectomy without clear evidence that the benefits outweigh 
the immediate and long-term risks.60–63 Moreover, it is unclear whether these conditions are 
associated with different levels of risk in certain cancers (e.g., vaginal cancer), and optimal 
screening for these conditions is poorly understood. Research to provide a better 
understanding of the processes that might put women with CGCs at risk for adult cancers 
and strategies to increase screening is needed.
Contraception and urological health: Addressing contraception issues for individuals with 
CGCs is critical, as many young adults may become sexually active during their transition. 
Individuals with CGCs may be at increased risk for latex sensitivity due to repeated latex 
exposure (e.g., latex catheters).64 Although dramatic changes have occurred over the last 20 
years to reduce exposure to latex for persons with CGCs (e.g., non-latex catheters, gloves 
and surgical equipment), the potential for latex sensitivity, especially in adults who may have 
had repeated exposures, continues. Options for barrier contraception—and associated risks
—for individuals with latex sensitivity need to be identified. Non-latex condoms are 
available and recommended for those with latex allergy, but in a review of adults without 
disability they were twice as likely to break or slip off during intercourse.65 In women with 
CGCs for whom pregnancy is possible, use of certain contraception methods may not be 
possible due to underlying anatomy. Some conditions may preclude the use of an intra-
uterine device, one of the safest methods of contraception. Associated comorbidities, such as 
hypertension due to renal disease, may preclude the use of estrogen-containing 
contraception.
Risks related to pregnancy/delivery: Pregnancy risks and safety in women with CGCs are 
limited to case reports, and delivery is associated with issues resulting from the underlying 
anatomy.66, 67 Reports point to increased risk of UTI, early delivery and Cesarean birth.66 
One observational study of pregnancy in women with cloacal/exstrophy reported a 100% 
Cesarean birth rate.66 If these women had had previous urological or gastrointestinal 
surgery, they may be at further risk during Cesarean delivery. However, the exact prevalence 
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of pregnancy complications and negative outcomes by CGC type are unknown, and factors 
that may mediate risk are poorly understood.
Activities and participation
Methods to improve sexual function and satisfaction: Despite anatomical variations or 
sexual function limitations, many men desire sexual contact68 and tend to engage in sexual 
activities despite these limitations.69 For women, sexual function is an important aspect of 
well-being and is significantly related to psychosocial issues, including body image and 
feelings of attractiveness. Barriers to sexual activity include incontinence,70 cognitive 
impairments,71 pain,72 mobility limitations, impairments in manual dexterity, reduced penile 
sensation in men,71 and libido in women, which in turn, can be affected by endocrine, 
anatomical and psychosocial issues. Men with conditions like spina bifida become sexually 
active later than their peers without disabilities, possibly in part due to living in their 
parents’ home well into adulthood.73 They also report lower sexual satisfaction compared 
with women.72
Women born with differences in sexual development (DSD) often delay sexual activity, 
possibly owing to anxiety about genital appearance and function. Several studies have 
reported that—across disability groups—adolescent females with DSD and other CGCs 
reported fewer sexual activities, initiation or receptivity to sexual activity, romantic appeal, 
and satisfaction than did their peers.74–76 Issues regarding privacy, relevant to many women 
with CGCs who may live with their parents until at least late adulthood, play a large role in 
women’s sexual experiences.74, 77–79 Research is needed to better understand the barriers to 
sexual participation in men and women with CGCs and to develop and validate interventions 
to overcome these barriers.
Educational models for delivering information about sexuality: Few individuals with 
limitations in sexual function receive sufficient sexual education from clinicians,80 and yet 
affected individuals report they are interested in discussing sexuality.81 The lack of 
information on the impact of spina bifida on sexuality has persisted during the past decade, 
with >30% of patients in 2002 and 2014 reporting having limited information despite 
ongoing interactions with healthcare providers.76, 79 Individuals with sexual limitations tend 
to lack sufficient knowledge about reproductive anatomy and physiology, available 
treatments for erectile or ejaculatory dysfunction, or methods of contraception or protection 
from disease. Among those who are sexually active, <20% use contraception.82 This lack of 
knowledge can restrict participation in sexual relationships, especially as an individual 
matures. Difficulties in establishing social relationships and poor self-perceptions of body 
image can compound the difficulty in establishing intimate relationships.71 Uncertainty 
about sexual function can also result in depression.83 Finally, the need for physical 
assistance can introduce concerns about privacy. Research is needed to determine how best 
to provide individuals with timely, accurate and useful information. In the meantime, those 
providing urological and gynecological healthcare to this population need to continually 
assess the understanding of structural and functional changes as they relate to sexuality and 
provide in-depth education for these complex conditions.
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Effects of incontinence on sexual activity: von Linstow, et al. found that fecal, but not 
urinary, incontinence was related to decreased sexual activity and satisfaction in men and 
women with spina bifida.79 By contrast, Game et al. found that UI was the major factor 
related to deceased sexual activity –decreased desire, arousal and receptivity – among 
women with myelomeningocele.74 Even the experience of wearing pads was seen as a 
barrier to intimacy.74 In men and women, sexual activity is associated with continence.70 
However, the risk and protective factors for psychological health for those dealing with 
incontinence is still not well understood and merits further research.
CONCLUSION
Research and clinical care have not kept pace with millions of adolescents and young adults 
with CGCs who are transitioning to adulthood owing to significant improvements in life 
expectancy. Because many urological issues emerge or evolve during adolescence and young 
adulthood, these issues and their impact on health, QoL, self-management and social 
participation outcomes in individuals with CGCs are poorly understood. Research is needed 
to better equip the healthcare system as a whole, pediatric and adult urologic and 
gynecologic providers, and individuals with CGCs to effectively manage these conditions—
particularly during the volatile period of transition from pediatric to adult care.
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Figure 1. Factors related to urologic care and outcomes across the lifespan
Across several functional domains—including health, social and emotional well-being, 
productivity and self-management— several factors related to urological and health 
outcomes become increasingly relevant during the period of transition from childhood to 
adulthood. For example, sexuality, functional independence, and integration into the 
workplace all demonstrate relatively greater importance during young adulthood than they 
did in pediatric life. UTI: urinary tract infection.
Hsieh et al. Page 18
Urology. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Schematic Diagram of Breakout Sessions by Groups and Topics of Discussion
The meeting included two sets of breakout groups. First, six multidisciplinary groups of 
participants identified research areas of highest and intermediate need across six condition-
based areas. Then, participants reassembled into six groups to organize the identified 
condition-based needs across scientific disciplines. Afterwards, all participants reconvened 
for a facilitated discussion to summarize major research needs. LUT: lower urinary tract; 
NGB: neurogenic bladder
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Table 2
Acquired conditions that may effect bladder management with aging by relevant specialty
Nephrological Urological Neurological Other
Chronic kidney
disease
Pelvic organ
prolapse
Nocturia
Overactive bladder
Cognitive
decline/cerebrovascular
accidents
Polypharmacy
Polyuria Prostatic
hyperplasia
Spinal stenosis
Failure to thrive in
young children
Prostate cancer Neuropathy
Examples of specific acquired conditions that may affect bladder management beyond childhood. Such conditions may be encountered by the 
treating urologist, neurologist, nephrologist, or other care providers and require prompt recognition and appropriate treatment to protect the kidneys 
from damage. For example, a patient who Valsalva voids through young adulthood may encounter retention, urinary tract infections, or new leakage 
as the prostate enlarges and creates increased outlet resistance.
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Table 3
Acquired conditions that may effect bladder management with aging by relevant condition
Spina bifida Cerebral Palsy
Bladder
Exstrophy
Prune Belly
Syndrome PUV
Loss of upper
extremity
dexterity
Progression to
atonic bladder
Pelvic organ
prolapse
Abdominal hernia Renal graft
deterioration
Obesity Extremity
contractures
Urethral
stricture
Bladder
deterioration
Spinal disease
Loss of
ambulatory
status
Abdominal
hernia
Examples of specific acquired conditions that may affect bladder management beyond childhood by primary diagnosis. Such conditions may impair 
the patient’s ability to perform bladder management or self care, and therefore place the patient at risk. For example, a spina bifida patient who self 
catheterizes through young adulthood may encounter increasing obesity, which would impair her ability to cleanly and safely catheterize her 
bladder per urethra in her chair, therefore subjecting her to risk of recurrent infections, retention, urinary incontinence and ultimately renal demise.
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